Repare Therapeutics

$26.35 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Repare Therapeutics

Repare Therapeutics Inc is a Canada-based precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations. Its approach integrates discoveries from several fields of cell biology including deoxyribonucleic acid (DNA) repair and synthetic lethality. Its SNIPRx platform combines a clustered regularly interspaced short palindromic repeats (CRISPR)-enabled gene editing target discovery method with protein crystallography, computational biology and clinical informatics.

Stock Analysis

last close $26.13
1-mo return 6.8%
3-mo return -23.1%
avg daily vol. 165.07T
52-week high 46.44
52-week low 19.01
market cap. $1.1B
forward pe -
annual div. -
roe -36.2%
ltg forecast -
dividend yield -
annual rev. $1M
inst own. 76.5%
baraka

Subscribe now for daily local and international financial news

Subscribe